Delivery Order SPE2DB24D1205-SPE2DB25FCWGD
Award Date
4/29/25
Potential Completion Date
4/30/25
Potential Value
$1.9K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, valued at $55,833.88, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Eliquis 5 mg tablets, a medication used to treat and prevent blood clots. This is a firm fixed-price delivery order contract with an ultimate completion date of April 17, 2025. The award is not set-aside and was competitively issued. AmerisourceBergen Drug...
This federal contract award, valued at $47,953.31, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order for the supply of Eliquis 5 mg tablets, a medication used to treat and prevent blood clots. The contract is a Firm Fixed Price arrangement with an ultimate completion date of April 22, 2025. This award is not associated with a set-aside program and represents...
This federal contract award, valued at $7,862.40, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Eliquis 5 mg tablets, a medication used to treat and prevent blood clots. The contract is a Delivery Order, with a Firm Fixed Price pricing type, and has an ultimate completion date of April 9, 2025. The contract is not set aside for any specific business type....
This federal contract award, valued at $11,367.70, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Eliquis 5 mg tablets, a medication used to treat and prevent blood clots. The contract is a Firm Fixed Price Delivery Order, with an ultimate completion date of April 16, 2025. It is not designated as a set-aside contract, indicating open competition....
This federal contract award, valued at $13,987.16, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Eliquis 5 mg tablets, a medication used to treat and prevent blood clots. The contract is a Firm Fixed Price Delivery Order with a Period of Performance through November 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with DLA...
This federal contract award is a delivery order valued at $11,984.53 issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of Eliquis 5 mg tablets, a prescription medication used to treat and prevent blood clots. The contract is a firm fixed-price, non-set-aside award with a performance period through May 2, 2025. AmerisourceBergen Drug Corp holds a larger Indefinite Delivery Contract (IDC) with DLA Troop...
This federal contract award, valued at $13,703.07, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order for the supply of Eliquis 5 mg tablets. It is a firm fixed-price contract with an ultimate completion date of April 16, 2025. The contract is not designated as a set-aside and represents an open competition award. AmerisourceBergen Drug Corp holds a significant...
This federal contract award, issued by the Defense Logistics Agency (DLA), was granted to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $7,129.73 firm fixed-price delivery order is for the supply of Eliquis 5 mg tablets, a medication used to treat and prevent blood clots. The contract has a period of performance through May 9, 2025 and does not have a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a...
This federal contract award, valued at $5,940.31, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order for the supply of Eliquis 5 mg tablets, a medication used to treat and prevent blood clots. The contract is a firm fixed-price, non-set-aside award with an ultimate completion date of April 10, 2025. Amerisourcebergen Drug Corp holds a substantial Indefinite...
This federal contract award, valued at $28,885.18, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The award is for the delivery of Eliquis 5 mg tablets, a medication used to treat and prevent blood clots. This is a firm fixed-price delivery order contract with a performance period extending through May 1, 2025. The contract is not set-aside and is open to full and open competition. Amerisourcebergen Drug Corp holds a...